Etoricoxib

5-Chloro-3-(4-methanesulfonyl-phenyl)-6’-methyl-\[2,3’\]bipyridinyl

Etoricoxib (CAS 202409-33-4) reference standard empowers precise LC-MS/MS and GC-MS quantification from the outset. Produced and distributed by WITEGA Laboratorien Berlin-Adlershof GmbH, it supports calibration, traceability, and confirmatory analysis in demanding workflows. As a pharmaceutical residue analysis standard and a selective cyclooxygenase two inhibitor standard, it fits research, quality control, and surveillance programs.

This material is manufactured with strict specifications for identity, purity, and content. Clear documentation and batch data enable reliable method validation. You can establish linearity, accuracy, precision, and limits with confidence. The reference standard dissolves in common solvents and shows robust stability. Therefore, it performs well across routine LC-MS/MS and GC-MS sequences.

• Traceable characterization supporting defensible reporting
• Calibrations for single residue and multi residue methods
• Verification of selectivity and absence of interference
• Recovery studies, robustness checks, and carryover assessment
• Fit for confirmatory analysis under regulated guidelines

Typical applications span regulated laboratories, pharmaceutical research, residue control monitoring, metabolism studies, and multi residue method development. Analysts in contract labs, manufacturers, and public agencies rely on this reference standard for day to day quantification and quality assurance.

Order directly from WITEGA Laboratorien Berlin-Adlershof GmbH. We provide flexible pack sizes and shipping options. Additionally, technical support helps with solvent selection, preparation, and storage. Use Etoricoxib (CAS 202409-33-4) reference standard to strengthen your traceability chain and to document compliance from calibration through confirmatory analysis.

You can download your Safety Data Sheet for NS035

For other languages please contact us: witega@witega.de